Evidence Synthesis via Indirect Treatment Comparisons in the European Framework of Joint Clinical Assessment
Alberto de la Cuadra-Grande, María Arruñada, Alejandro García-Solís, Ana Rossignoli-Montero, Miguel Ángel Casado · 2026
Read Evidence Synthesis via Indirect Treatment Comparisons in the European Framework of Joint Clinical Assessment by Alberto de la Cuadra-Grande, María Arruñada, Alejandro García-Solís, Ana Rossignoli-Montero, Miguel Ángel Casado (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214821.txt.
Description
Alberto de la Cuadra-Grande and co-authors explain a method in a 2026 paper on European drug assessment. New EU rules create joint clinical assessments across member states. Each joint review must frame one question that fits all countries: which patients, which drug, what it is compared with, and which outcomes count.
When trials compare a drug against the same rival, direct pooling works. When rivals differ between trials, indirect comparisons must bridge the gap. The report lays out a clear framework for when those bridges are sound and how to read their results. Assessors across Europe can then judge new drugs on a shared footing.
Catalog record
| CREATOR | Alberto de la Cuadra-Grande, María Arruñada, Alejandro García-Solís, Ana Rossignoli-Montero, Miguel Ángel Casado |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |